Last update 15 Jul 2026

Lanoracopan Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MY-008, MY008, MY008211A
+ [1]
Target
Action
inhibitors
Mechanism
CFB inhibitors(Complement factor B inhibitors)
Inactive Indication
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (10 Jun 2026),
RegulationOrphan Drug (United States), Breakthrough Therapy (China), Priority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H32N2O4
InChIKeyYJJUEZFALZMWAP-URXFXBBRSA-N
CAS Registry2797066-85-2

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemoglobinuria, Paroxysmal
China
10 Jun 2026
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glomerulonephritis, IGAPhase 2
China
30 Nov 2024
HemolysisPhase 2
China
06 Jul 2023
C3 glomerulopathyIND Approval
China
18 Dec 2023
Diabetic NephropathiesIND Approval
China
18 Dec 2023
Idiopathic Membranous GlomerulonephritisIND Approval
China
18 Dec 2023
Lupus NephritisIND Approval
China
18 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
68
MY008211A 400 mg
yxjatiiudg(nebflofnwr) = The most common adverse events with MY008211A were neutrophil count decreased (29.4%), upper respiratory infection (26.5%), and white blood cell count decreased (23.5%). No major adverse vascular events occurred in either arm. ziqsuenqqi (mtfpvqjmjx )
Positive
12 May 2026
Phase 3
20
MY008211A 400 mg
updrvnmfnk(skjcaqvezr) = ysvqbwmtwb zjilzekgwz (xtyubxuiyy )
Positive
12 May 2026
Phase 2
-
ysqaixkvnt(qtmfrtxnba) = n=15 of 34 patients laedaxblec (asgprmhnxn )
-
08 Dec 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free